Skip to content
Screener

LivaNova LIVN Research and development costs

Research and development costs at other companies

Match Group logo
Match GroupMTCH
$99.44M-22.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$1.28M-47.9%
Everspin Technologies logo
Everspin TechnologiesMRAM
$4.37M-31.8%
Crane NXT, Inc. logo
Crane NXT, Inc.CXT
$16.9M+5.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.21B+55.7%
Enterprise value$4.05B+55.9%
P/E22.8×-68.5×
P/S2.9×+0.8×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept livn:ResearchAndDevelopmentCostsPayableCurrent.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemJune 30, 2026December 31, 2025
Royalty accrual5,3144,758
Provisions for agents, returns, and other3,9335,322
Interest payable2,9114,638
Tariff refund payable1,943
Research and development costs1,2511,234
Current derivative liabilities6199
Other accrued expenses33,64026,989
$103,831$94,573

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's research and development costs?
LivaNova (LIVN) reported research and development costs of $1.25M in Q2 2026.
How has LivaNova's research and development costs changed year-over-year?
LivaNova's research and development costs decreased by 26.9% year-over-year, from $1.71M to $1.25M.
What is the long-term trend for LivaNova's research and development costs?
Over 5 years (2020 to 2025), LivaNova's research and development costs has grown at a -21.9% compound annual growth rate (CAGR), from $4.26M to $1.23M.
What does research and development costs mean?
Research and development costs as reported by LivaNova PLC Ordinary Shares.

Ask your AI about LivaNova's research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude